Learn about metabolomics, biology's fourth language that has remained vastly untapped up until now and could accelerate ...

Silicon Valley-based law firm Fenwick & West LLP is expanding its East Coast footprint with the launch of a new Boston office ...

Sana Biotechnology, Inc.’s SANA share price has surged by 6.21%, which has investors questioning if this is right time to ...

It was while Karolina Valente was wrapping her PhD at the University of Victoria that she discovered a blind spot in cancer ...

Japanese agrifoodtech funding increased in 2024 thanks to a major deal in biomaterials and a handful of deals for restaurant ...

Listen to this article Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and ...

Biotechnology will have a transformative impact on defense, supply chains, agriculture, health and computing, all areas that ...

Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and ...

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Radiopharm Theranostics Limited (NASDAQ:RADX). The reason why I want to go over this ...

Fintel reports that on March 25, 2025, Maxim Group upgraded their outlook for Moleculin Biotech (NasdaqCM:MBRX) from Hold to Buy. Analyst Price Forecast Suggests 1,632.08% Upside As of March 19 ...